Michael Mitchell

Michael Mitchell is vice-president of chemical development at Schering-Plough Research Institute.

Articles

PhRMA Perspectives on Drug Substance Regulatory Filing Issues

February 2nd 2003

The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.

Latest Updated Articles

Published: October 11th 2024 | Updated: October 18th 2024

Buy, Sell, Hold: Cell and Gene Therapy - Part 1

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 10th 2024 | Updated: September 18th 2024

CPHI Milan Announces 2024 CPHI Pharma Award Finalists

Published: November 22nd 2024 | Updated: November 25th 2024

The Pharmacy Advantage in Direct-to-Patient Clinical Supply

Published: October 28th 2024 | Updated: November 25th 2024

Discovery to Commercialization: The Right Partnerships are Key to Streamlined Drug Development

Operator work on infusion pharmaceutical industry | Image Credit: © xmagics - © xmagics - stock.adobe.com

Published: November 6th 2024 | Updated: November 25th 2024

Automate Aseptic Filling: Closing the System at Full Modularity

Two scientists wearing lab coats and safety glasses analyzing data displayed on a computer screen in a laboratory setting | Image Credit: © NCST Studio - © NCST Studio - stock.adobe.com

Published: November 5th 2024 | Updated: November 25th 2024

Untethered Data: Unifying and Contextualizing Drug Discovery Data

About Us

Advertise

Editorial Info

Editorial Advisory Board

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777